Named as a key player in 297 of our reports, across 33 regions and countries.
2023–2033 CAGR · estimates
| Market | Category | World 2023 | CAGR |
|---|---|---|---|
| Nutritional Supplements | OTC & Nutraceuticals | $385 Bn | 6.8% |
| Dietary Supplements | OTC & Nutraceuticals | $308 Bn | 6.2% |
| Women's Health Supplements | OTC & Nutraceuticals | $20 Bn | 6.8% |
| Bone & Joint Health Supplements | OTC & Nutraceuticals | $12 Bn | 6.4% |
| Cardiovascular Health Supplements | OTC & Nutraceuticals | $6.8 Bn | 5.7% |
| Osteoporosis Supplements | OTC & Nutraceuticals | $3.1 Bn | 6.5% |
| Iron Supplement | OTC & Nutraceuticals | $2 Bn | 6.5% |
| Biotin Supplement | OTC & Nutraceuticals | $400 Mn | 5% |
| Weight Management Supplement | OTC & Nutraceuticals | – | – |
Named as key players in the same markets as Amway (number of shared markets).
Pfizer Inc.4 shared markets
Bayer AG3 shared markets
Glanbia PLC3 shared markets
Nestle3 shared markets
Arazo Nutrition2 shared markets
GNC Holding Inc.2 shared markets
Herbalife International of America, Inc2 shared markets
Herbalife Nutrition2 shared markets